/Lists

Biotech Investors & VC Firms in North America

1593 firms in this list, with a median first check of $500K. 347 of them lead rounds. Generated from verified public data and updated continuously.

Ally Bridge Group
New YorkGrowth–Late Stage
7 people
Crossbeam Venture Partners
New YorkPre-Seed–Late Stage$1M – $1.5M
7 people
Page One Ventures
Silicon ValleyPre-Seed–Series A
4 people
Rock Springs Capital
BaltimoreLate Stage
13 people
Bridge Bank
San FranciscoSeed–Late Stage
18 people
Sv Tech Ventures, Inc.
Palo AltoSeed–Series A
9 people
Fall Line Capital
San MateoSeries A–Series C
11 people
Martlet Capital
CambridgePre-Seed–Series A$317.5K
8 people
New Science Ventures
GreenwichSeed–Late Stage$2M – $8M
7 people
IDL Ventures
ChicagoSeed–Series A
21 people
Life Sciences Greenhouse Investments
HarrisburgPre-Seed–Series B$250K – $500K
12 people
Creative Ventures
San Francisco Bay AreaPre-Seed–Series A$1M
8 people
Genoa Ventures
San FranciscoPre-Seed–Series A
14 people
Amplitude Venture Capital
MontrealPre-Seed–Series B
16 people
BrightEdge
AtlantaPre-Seed–Late Stage
15 people
CTI Life Sciences Fund L.P.
MontréalSeed–Late Stage
9 people
LifeSci Venture Partners
New YorkSeries A–Series C
6 people
Rockies Venture Club
DenverSeed–Series A$100K – $500K
3 people
First Star Ventures
CambridgePre-Seed–Seed$100K – $1M
5 people
Borealis Ventures
HanoverPre-Seed–Series A$1M – $2.5M
13 people
Formation Venture Engineering
BostonPre-Seed
19 people
IKJ Capital
Palo AltoSeed–Series A
11 people
Pathway to Cures
New YorkSeed–Series A
20 people
AbbVie
CambridgeSeed–Late Stage$300K – $3M
13 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.